S&P 500   5,069.91 (+1.77%)
DOW   38,918.78 (+0.79%)
QQQ   436.20 (+2.49%)
AAPL   182.79 (+0.26%)
MSFT   409.19 (+1.74%)
META   487.69 (+4.20%)
GOOGL   143.63 (+0.76%)
AMZN   172.84 (+2.52%)
TSLA   195.74 (+0.50%)
NVDA   776.63 (+15.10%)
NIO   5.77 (-3.35%)
AMD   183.32 (+11.58%)
BABA   76.00 (+0.56%)
T   16.69 (-1.82%)
F   12.18 (+0.33%)
MU   85.45 (+4.86%)
CGC   3.41 (-0.87%)
GE   151.80 (+1.83%)
DIS   108.15 (+0.45%)
AMC   4.39 (-3.94%)
PFE   27.41 (-0.94%)
PYPL   58.35 (+1.51%)
XOM   104.91 (+0.06%)
S&P 500   5,069.91 (+1.77%)
DOW   38,918.78 (+0.79%)
QQQ   436.20 (+2.49%)
AAPL   182.79 (+0.26%)
MSFT   409.19 (+1.74%)
META   487.69 (+4.20%)
GOOGL   143.63 (+0.76%)
AMZN   172.84 (+2.52%)
TSLA   195.74 (+0.50%)
NVDA   776.63 (+15.10%)
NIO   5.77 (-3.35%)
AMD   183.32 (+11.58%)
BABA   76.00 (+0.56%)
T   16.69 (-1.82%)
F   12.18 (+0.33%)
MU   85.45 (+4.86%)
CGC   3.41 (-0.87%)
GE   151.80 (+1.83%)
DIS   108.15 (+0.45%)
AMC   4.39 (-3.94%)
PFE   27.41 (-0.94%)
PYPL   58.35 (+1.51%)
XOM   104.91 (+0.06%)
S&P 500   5,069.91 (+1.77%)
DOW   38,918.78 (+0.79%)
QQQ   436.20 (+2.49%)
AAPL   182.79 (+0.26%)
MSFT   409.19 (+1.74%)
META   487.69 (+4.20%)
GOOGL   143.63 (+0.76%)
AMZN   172.84 (+2.52%)
TSLA   195.74 (+0.50%)
NVDA   776.63 (+15.10%)
NIO   5.77 (-3.35%)
AMD   183.32 (+11.58%)
BABA   76.00 (+0.56%)
T   16.69 (-1.82%)
F   12.18 (+0.33%)
MU   85.45 (+4.86%)
CGC   3.41 (-0.87%)
GE   151.80 (+1.83%)
DIS   108.15 (+0.45%)
AMC   4.39 (-3.94%)
PFE   27.41 (-0.94%)
PYPL   58.35 (+1.51%)
XOM   104.91 (+0.06%)
S&P 500   5,069.91 (+1.77%)
DOW   38,918.78 (+0.79%)
QQQ   436.20 (+2.49%)
AAPL   182.79 (+0.26%)
MSFT   409.19 (+1.74%)
META   487.69 (+4.20%)
GOOGL   143.63 (+0.76%)
AMZN   172.84 (+2.52%)
TSLA   195.74 (+0.50%)
NVDA   776.63 (+15.10%)
NIO   5.77 (-3.35%)
AMD   183.32 (+11.58%)
BABA   76.00 (+0.56%)
T   16.69 (-1.82%)
F   12.18 (+0.33%)
MU   85.45 (+4.86%)
CGC   3.41 (-0.87%)
GE   151.80 (+1.83%)
DIS   108.15 (+0.45%)
AMC   4.39 (-3.94%)
PFE   27.41 (-0.94%)
PYPL   58.35 (+1.51%)
XOM   104.91 (+0.06%)
TSE:TH

Theratechnologies (TH) Stock Price, News & Analysis

C$2.15
-0.14 (-6.11%)
(As of 12:16 PM ET)
Today's Range
C$2.15
C$2.33
50-Day Range
C$1.97
C$3.05
52-Week Range
C$1.22
C$5.84
Volume
56,115 shs
Average Volume
51,576 shs
Market Capitalization
C$105.78 million
P/E Ratio
N/A
Dividend Yield
3.76%
Price Target
C$5.50

Theratechnologies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
146.6% Upside
C$5.50 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.09mentions of Theratechnologies in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.08 out of 5 stars


TH stock logo

About Theratechnologies Stock (TSE:TH)

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; and TH1902, which is in Phase 1 clinical trials for the treatment of various solid tumors, including HR+ breast cancer, triple negative breast cancer, ovarian cancer, endometrial cancer, melanoma, thyroid cancer, small cell lung cancer, and prostate cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

TH Stock Price History

TH Stock News Headlines

Stock To Watch In 2024
Don't wait. Discover this company's major updates happening now.
Here's what Wall Street expects from Theratechnologies's earnings report
7THTX : Theratechnologies Earnings Preview
Theratechnologies (TH) Scheduled to Post Earnings on Wednesday
Stock To Watch In 2024
Don't wait. Discover this company's major updates happening now.
3 Biotech Stock Buys to Boost and Supercharge Portfolios
Closing Bell: Theratechnologies flat on Monday (TH)
See More Headlines
Receive TH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
144
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$5.50
High Stock Price Target
C$5.50
Low Stock Price Target
C$5.50
Potential Upside/Downside
+146.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
C$-29,130,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$79.73 million
Cash Flow
C$0.59 per share
Book Value
C($1.72) per share

Miscellaneous

Free Float
N/A
Market Cap
C$109.72 million
Optionable
Not Optionable
Beta
1.75
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Paul Lévesque (Age 60)
    President, CEO & Director
    Comp: $1.77M
  • Mr. Philippe Dubuc M.B.A. (Age 57)
    MBA, Senior VP & CFO
    Comp: $606.23k
  • Mr. Jocelyn Lafond L.L.M. (Age 56)
    LL.B., General Counsel & Corporate Secretary
    Comp: $439.23k
  • Dr. Christian Marsolais Ph.D. (Age 61)
    Senior VP & Chief Medical Officer
    Comp: $629.22k
  • Mr. John Leasure (Age 59)
    Global Commercial Officer
    Comp: $692.75k
  • Hon. Andre Dupras M.Sc. (Age 60)
    Vice President of Human Resources














TH Stock Analysis - Frequently Asked Questions

Should I buy or sell Theratechnologies stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TH shares.
View TH analyst ratings
or view top-rated stocks.

What is Theratechnologies' stock price target for 2024?

2 brokers have issued twelve-month target prices for Theratechnologies' stock. Their TH share price targets range from C$5.50 to C$5.50. On average, they expect the company's stock price to reach C$5.50 in the next year. This suggests a possible upside of 146.6% from the stock's current price.
View analysts price targets for TH
or view top-rated stocks among Wall Street analysts.

How have TH shares performed in 2024?

Theratechnologies' stock was trading at C$2.14 on January 1st, 2024. Since then, TH shares have increased by 4.2% and is now trading at C$2.23.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Theratechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Theratechnologies investors own include Stars Group (TSGI), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Nemaska Lithium (NMX), Shopify (SHOP), United Therapeutics (UTHR) and Avigilon (AVO).

How do I buy shares of Theratechnologies?

Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:TH) was last updated on 2/22/2024 by MarketBeat.com Staff